Effects of remimazolam besylate on postoperative recovery quality in patients with vocal cord lesion resection

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2300068097

Enrollment

Unknown

Registered

2023-02-07

Start date

2023-02-10

Completion date

Unknown

Last updated

2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

polyp of vocal cord

Interventions

Remazolam group:General anesthesia was induced and maintained with remazolam

Propofol group:General anesthesia was induced and maintained with propofol

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. ASA grade I or II; 2. Age 18 to 60 years old, BMI of 18 to 25kg/^2; 3. Willing to accept the trial and study treatment and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with a history of severe heart, brain, lung, liver, kidney and metabolic diseases. 2. Have a history of alcoholism, sleeping pills; 3. Preoperative systolic blood pressure >180mmHg and/or diastolic blood pressure > 110mmHg in hypertensive patients; 4. People with neuromuscular system diseases and mental diseases; 5. Suspected abuse of narcotic analgesics or sedatives; 6. People with known allergies to benzodiazepines and opioids.

Design outcomes

Primary

Measure	Time frame
Postoperative recovery quality score QoR-15;Effects on hemodynamics;	—

Secondary

Measure	Time frame
untoward effect;Effect of sedation;	—

Countries

China

Contacts

Public ContactKai Wang

Xinxiang Central Hospital

422018818@qq.com+86 150 9031 3121

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026